Subscribe: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition
http://www.newswiretoday.com/xml/17/
Preview: NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition

NewswireToday - Free Press Release - Free Newswire Distribution - Pharma/BioTech/Nutrition



Recent Pharma/BioTech/Nutrition NewswireToday - PRZOOM Headline News - Visit PressReleasesNewswireDistribution.com



Published: Wed, 28 Sep 2016 11:48:27 -0400

 



American Science and Technology Awarded Second New Patent

2016/09/27

NewswireToday (newswire) - 2016/09/27 Chicago, IL United States - New Patented Process Can Produce High Quality Pulp As Well As Desirable Bio-Renewable Materials - AmSnT.com



BD Invests $100 Million in Nebraska Plant to Expand Insulin Syringe Manufacturing

2016/09/22

NewswireToday (newswire) - 2016/09/22 Franklin Lakes, NJ United States - BD announced it is investing $100 million in its Holdrege, Neb. facility to expand capacity for its insulin syringe manufacturing operations - BD.com



BD Unveils Next Generation Wireless Point-of-Care Diagnostic Device

2016/09/21

NewswireToday (newswire) - 2016/09/21 Franklin Lakes, NJ United States - New BD Veritor™ Plus System Enables Fast and Accurate Test Results for Health Care Providers - BD.com



BD and Vancive Medical Technologies Launch New Vascular Dressings with CHG Antimicrobial

2016/09/16

NewswireToday (newswire) - 2016/09/16 Franklin Lakes, NJ United States - BD ChloraShield™ Dressings are Now Available for a Range of Vascular Access Procedures [NYSE:AVY] - AveryDennison.com / BD.com



Sartorius Stedim Biotech Presents Sartocon® Slice 50 ECO

2016/09/15

NewswireToday (newswire) - 2016/09/15 Goettingen, Germany - New small-scale crossflow device for low-viscosity water-based protein solutions - Sartorius-Stedim.com



European Commission Approves Ipsen’s Cabometyx™ (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma (RCC) in Adults

2016/09/14

NewswireToday (newswire) - 2016/09/14 Paris, Ile-de-France France - European Commission approves Ipsen’s Cabometyx™ (cabozantinib) Tablets for the treatment of advanced renal cell carcinoma (RCC) in adults following prior vascular endothelial growth factor (VEGF)-targeted therapy - IPSEN.com



BTG Launches βETA™ Radiation Safety Programme, to Reduce the Risk of Radiation Exposure for Healthcare Professionals and Patients

2016/09/09

NewswireToday (newswire) - 2016/09/09 Ottawa, Québec Canada - BTG plc announced the launch of the βETA™ Radiation Safety Programme, a new initiative designed to reduce the risk of radiation exposure when performing selective internal radiation therapy (SIRT) with 90Y microspheres - BTG-IM.com



Collaborations Between Pharma and Diagnostic Companies Boost Growth for Neurodiagnostics Finds Frost & Sullivan

2016/09/06

NewswireToday (newswire) - 2016/09/06 London, United Kingdom - Diagnostics for a wide range of neurodegenerative diseases are benefiting from new neuroinformatic platforms, finds Frost & Sullivan’s TechVision Team - Frost.com



Sartorius Stedim Biotech Presents the First Fully Integrated Upstream Platform

2016/09/01

NewswireToday (newswire) - 2016/09/01 Goettingen, Germany - Unique product and service portfolio extensively covers all steps from cell line development to commercial manufacturing processes - Sartorius-Stedim.com



IPSEN Biopharmaceuticals, Inc. Announces FDA Approval of Dysport® (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Pediatric Patient

2016/09/01

NewswireToday (newswire) - 2016/09/01 Basking Ridge, NJ United States - Ipsen Biopharmaceuticals, Inc. Announces FDA Approval of Dysport® (abobotulinumtoxinA) for the Treatment of Lower Limb Spasticity in Pediatric Patients Aged Two and Older - IPSENCARES.com



MDxHealth and Teva Pharmaceuticals Sign Distribution Agreement for SelectMDx in Israel

2016/08/31

NewswireToday (newswire) - 2016/08/31 Herstal, Belgium - MDxHealth SA announced that it has signed a distribution agreement with Teva Pharmaceuticals to offer its SelectMDx™ for Prostate Cancer test to Teva's urology customers throughout Israel [NYSE and TASE: TEVA] - TevaPharm.com / MDxHealth.com



BTG Receives Health Canada Approval for DC Bead LUMI™

2016/08/25

NewswireToday (newswire) - 2016/08/25 Ottawa, Québec Canada - First commercially available radiopaque drug-eluting bead in Canada that provides real-time visible confirmation of bead location during embolization for the treatment of tumours in patients with HCC and mCRC - BTGplc.com



Greenphire Named to Inc. 5000 List of Fastest-Growing Companies for Fourth Consecutive Year

2016/08/24

NewswireToday (newswire) - 2016/08/24 King of Prussia, PA United States - Greenphire, the global leader in clinical payment solutions, has been named to the Inc. 5000 list of fastest-growing private companies in America for the fourth year in a row - Inc.com / Greenphire.com



Janki to Exhibit At The Asia Labex 2016, International Exhibition & Conference on Laboratory, Scientific Instruments and Consumables in Gujarat

2016/08/23

NewswireToday (newswire) - 2016/08/23 Ahmedabad, Gujarat India - Janki Impex is pleased to be an EXHIBITOR at the Asia Labex 2016, International Exhibition & Conference on Laboratory, Scientific Instruments and Consumables in Gujarat, India - 22nd-24th September 2016 - JankiImpex.com



CMS Grants Vistogard® New Technology Add-on Payment Status Effective 1 October 2016

2016/08/17

NewswireToday (newswire) - 2016/08/17 West Conshohocken, PA United States - BTG plc announces that Centers for Medicare and Medicaid Services (CMS) has approved a New Technology Add-on Payment (NTAP) for Vistogard®, effective 1 October 2016 - Vistogard.com / BTGplc.com